Corundum Neuroscience
Overview
Corundum Neuroscience is a neuroscience-focused venture builder and fund that works with researchers and entrepreneurs to build and grow companies developing solutions for health and disease areas, including anxiety, depression, PTSD, chronic pain, sleep, and neurodegenerative disorders.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| Vi Labs | Jun 2018 | Series A | - |
| NextSense, Inc. | Nov 2025 | Series A | Co-investor |
| Myndlift | Dec 2020 | Series A | Lead |
| NeuraWorx Medical Technologies | Dec 2025 | Seed | Co-investor |
| Pheno.AI | Nov 2024 | VC Round | Co-investor |
For institutional investors. Book with your work email.
Key People
Kenji Takeda
Co-Founder
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Corundum Neuroscience based?
Corundum Neuroscience is headquartered in Herzliya, Israel.
When was Corundum Neuroscience founded?
Corundum Neuroscience was founded in 2023.
How many portfolio companies does Corundum Neuroscience have?
Corundum Neuroscience has 9 portfolio companies in Caplight's dataset.
What are some companies in Corundum Neuroscience's portfolio?
Portfolio companies visible on Caplight include Vi Labs, NextSense, Inc., Myndlift, NeuraWorx Medical Technologies, Pheno.AI.
What was Corundum Neuroscience's most recent investment shown here?
Corundum Neuroscience's most recent investment in this portfolio sample was in NeuraWorx Medical Technologies in 2025.
What sectors does Corundum Neuroscience focus on?
Corundum Neuroscience focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Enterprise Software, AI, Data & Cloud Infrastructure, Consumer & Commerce, Consumer & Commerce, Consumer & Commerce, Enterprise Software, Frontier & Industrial Tech, Frontier & Industrial Tech.
What company stages does Corundum Neuroscience focus on?
Corundum Neuroscience typically invests at the Early stage.
What is Corundum Neuroscience's AUM?
Corundum Neuroscience's assets under management are estimated between $12.5M and $12.5M.